Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology operates in the dental and orthodontic medical device sector, where news typically centers on product innovations, clinical study results, regulatory approvals, and quarterly financial performance. The company's announcements often involve new features for the Invisalign clear aligner system, updates to iTero scanner technology, and expansion into new geographic markets or treatment applications.
Investors and dental professionals following Align Technology track earnings reports that break down Clear Aligner segment performance versus Scanner and Services revenue. These reports reveal trends in case volume, average selling prices, and adoption rates among orthodontists versus general practitioner dentists. The company also announces clinical partnerships, research collaborations, and professional education initiatives that affect market penetration.
Product launch announcements detail new aligner systems designed for specific patient populations or clinical scenarios, while scanner updates often involve new software capabilities or imaging improvements. Regulatory filings and approvals in international markets signal geographic expansion opportunities. The company occasionally discloses intellectual property developments, including patent grants and litigation related to clear aligner technology.
This news feed provides access to material announcements affecting Align Technology's business operations, competitive position, and financial results. Monitor this page for developments that may influence the company's market share in orthodontic treatment and digital dental imaging.
Align Technology (ALGN) reported robust Q1'23 financial results, achieving $943.1 million in total revenues, a 4.6% sequential increase but a 3.1% decline year-over-year. Clear Aligner revenues reached $789.8 million, up 7.9% sequentially, though down 2.5% year-over-year. Operating income was $133.5 million with a 14.2% operating margin. The company completed a $1 billion stock repurchase program and authorized a new $1 billion program. Align treated over 15 million global Invisalign patients and reported a net income of $87.8 million, or $1.14 per diluted share. For Q2'23, the anticipated revenue range is $980 million to $1,000 million, with expectations of improved Clear Aligner volume and ASP.
Align Technology has been recognized as the “Technology Partner of the Year” by Junior Achievement of Northern California at its 2023 Business Hall of Fame event in San Francisco. This accolade highlights Align's commitment to supporting education and community engagement through partnerships. Additionally, Julie Paulsen, Align's VP of Corporate Social Responsibility, was nominated as a 2023 “Volunteer of the Year” for her significant contributions. Align's philanthropic efforts include a $250,000 donation to Junior Achievement Worldwide in celebration of the company's 25th anniversary. Align encourages employee involvement in community services and educational mentoring, reflecting its core values of innovation and social responsibility.
Align Technology, Inc. (NASDAQ: ALGN) will report its first quarter 2023 financial results on April 26, 2023, after market close. Results will be released at 4:00 p.m. ET and will be accessible on the company's Investor Relations website. Following the report, a conference call is scheduled for 4:30 p.m. ET, which will be available via audio webcast. A replay of the call will be accessible for one month after the event. Align Technology specializes in advanced digital dentistry, including the Invisalign® System and iTero™ scanners, serving over 239,000 doctors and reaching a potential market of 500 million consumers globally.
Align Technology, Inc. (NASDAQ: ALGN) announces the departure of Yuval Shaked, EVP and Managing Director of iTero scanner and services, after nearly six years for personal reasons. He will assist during the transition to Karim Boussebaa, effective immediately from February 27. Boussebaa, with over 28 years of healthcare leadership experience, previously led multiple business units at Philips Healthcare. President and CEO Joe Hogan praised both Shaked’s contributions and Boussebaa's qualifications, expressing confidence in Boussebaa’s ability to drive growth in the iTero business.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
